Sentences with phrase «effects on other drugs»

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced liver, pancreas, thyroid, adrenal gland or kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has any congenital heart defects If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has a history of blood clots, Addison's disease or congestive heart failure If your pet has experienced liver or kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced anemia, liver or kidney disease now or ever If your pet has experienced diabetes or any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced liver or kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever If your pet is pregnant or nursing or if you plan to breed your pet Storage and Warnings:

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced liver or kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines (including tick collars) and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced liver disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced digestive upset now or ever If your pet has experienced liver or kidney disease now or ever If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

If your pet has experienced side - effects on other drugs / products If your pet has experienced any other medical problems or allergies now or ever All medicines and supplements that you are giving your pet or plan to give your pet, including those you can get without a prescription.

Not exact matches

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

That could have a domino effect on the other middlemen between Mylan and the patient, such as drug distributors, pharmacy benefit managers, and pharmacies, who might also have to settle for less revenue per EpiPen sale.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SDrug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the Sdrug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

According to Living Goods, clients may also be reluctant to buy drugs from other private providers because of the risk of getting a counterfeit medicine.63 Living Goods sent us a study conducted at the midline of its RCT that claims that both availability of counterfeit drugs and drug prices decreased at private retailers in areas where CHPs worked.64 According to the study, about 37 % of private drug shops in the areas it studied sold fake ACT drugs, 65 and availabilty of fake ACTs was about 50 % lower among non-Living Goods sellers in the areas where Living Goods worked.66 Additional results on these potential effects will be made available when the full RCT is published.

On the other hand, ending the drug war would free drug control officers to concentrate on protecting children from exploitation, and here stiff penalties would continue to be in effecOn the other hand, ending the drug war would free drug control officers to concentrate on protecting children from exploitation, and here stiff penalties would continue to be in effecon protecting children from exploitation, and here stiff penalties would continue to be in effect.

That could have a range of consequences, including effects on blood sugar, regulation of body weight, inflammatory bowel disease, and how drugs and other chemicals are absorbed and metabolized by the body.

They can model both healthy and unhealthy behaviors of their parents so the parents should be careful about their attitude about certain activities, alcohol, tobacco, drugs and other substances as this can have a significant effect on the future behavior of their children.

Naloxone can reverse a heroin or other opiate drug overdose within minutes, but it has no effect on people who do not have an opiate drug in their system and side effects are rare, according to information from the DuPage Narcan Program given to Orland Park trustees.

Every source I have found on fenugreek and other herbal sources are much more complete regarding drug interactions, allergies, side effects, etc..

Other drugs such as Oxytocin nasal spray, Sulpiride, Thorazine, TRH, and Human Growth Hormone may also have a positive effect on breast milk supply, but they are not as commonly used.

Lactmed is a database that contains information on drugs and other chemicals to which breastfeeding mothers may be exposed, as well as their effects on nursing infants.

«Baroness Smith of Basildon to move that this House regrets that Her Majesty's Government's plans for the introduction of the draft Misuse of Drugs Act 1971 (Amendment)(No. 2) Order 2014 do not include provisions for a 12 - month review of the impact of the reclassification of khat in view of the highly unusual community focus of its use, for putting a detailed policing strategy in place before a ban takes effect, or for a health strategy to prevent a transfer of addiction to other substances; and do not commit the Department for International Development to do more work with the government of Kenya to alleviate the effect of the reclassification on the Kenyan economy.»

For example, when people with bipolar disorder who have previously attempted suicide begin taking lithium, they tend to stop attempting suicide even if the drug has no effect on their other symptoms.

The scientists believe the drug targets a stress pathway specific to alcoholics because it has been shown to have little effect on stress levels in other types of patients.

Austad says other medications have shown similar effects on extending mouse life span, including acarbose (a common drug prescribed for Type 2 diabetes), and anti-inflammatory drugs such as masoprocol and basic aspirin.

The materials that pharmaceutical companies use to test drugs» effects on cells don't allow for three - dimensional vascularization, a network of capillaries that carry drugs and other materials throughout the body.

«Most researchers have relied on cell lines to screen the effect of drugs and other treatments including viruses,» said Dr. Cripe, who also is a professor at The Ohio State University College of Medicine.

Eventually the promise of other drug targets, along with the possible side effects of targeting NPY, put a damper on the effort — until now.

Seventy per cent of the websites provided information on the safe usage of prescription medications, including potential side effects or adverse reactions when combined with other drugs.

On the other side of the cocaine high is the cocaine crash, and understanding how one follows the other can provide insight into the physiological effects of drug abuse.

Used in the manufacturing of cosmetics, clothing, paints, food, drug delivery systems and many other familiar products we all use daily, little is known about the effects these materials have on health.

The challenge, of course, is to somehow meld a bewildering array of data sets: all sorts of historic and current medical records about each person and all sorts of scientific reports on a number of drugs, drug tests, potential side effects and outcomes for other patients.

Further scientific investigation is warranted to determine how the drug achieves its effects as well as how they might be used in the treatment of «the ennui and anguish of impending death» as well as «alcoholism and other forms of drug addiction,» argues Charles Schuster, a neuroscientist at Wayne State University and a former director of the National Institute on Drug Abuse, in a commentary on the padrug achieves its effects as well as how they might be used in the treatment of «the ennui and anguish of impending death» as well as «alcoholism and other forms of drug addiction,» argues Charles Schuster, a neuroscientist at Wayne State University and a former director of the National Institute on Drug Abuse, in a commentary on the padrug addiction,» argues Charles Schuster, a neuroscientist at Wayne State University and a former director of the National Institute on Drug Abuse, in a commentary on the paDrug Abuse, in a commentary on the paper.

Other drugs have the opposite effect on dopamine and compress the subjective experience of time.

Dr. Bachhuber and coauthors conclude: «To fully understand the effect of medical cannabis on the use of other drugs, prospective longitudinal studies randomizing patients to cannabis versus other treatments are urgently needed.»

«Although the effects of the drug were modest, we now know that we can influence the course of the disease, and we expect to build on this success with other drugs, including some already in development,» said senior author, Gary K. Schwartz, MD, professor of medicine and chief of hematology / oncology at NewYork - Presbyterian / Columbia University Medical Center and associate director of its Herbert Irving Comprehensive Cancer Center.

These were thought to be ketamine's target, but clinical trials of other drugs that target them have largely yielded disappointing effects on depression, says Gould.

Combine your articles on psilocybin and other psychedelic drugs having beneficial effects on the brain (such as 25 November 2017, p 28) with the promising reports of 40 hertz bass tones and flickering lights reducing the tangles and plaques of tau and amyloid proteins that are correlated with Alzheimer's disease (6 January, p 6).

After hearing about his work, several other companies, including Pfizer, Bayer, and Eli Lily, decided to examine the effects of different genetic variants on the efficacy and safety of drugs they had in development.

But although the florid hallucinations and other effects of LSD are well known, their neurobiological bases have been less clear, partly because of restrictions placed on the drug after its recreational heyday in the 1960s.

«With our chip, you can distribute a drug and then look for the effects on other tissues and measure the exposure and how it is metabolized.»

The authors examined whether the drug helped reduce a variety of pregnancy complications as a whole, rather than scrutinizing its effects on venous thromboembolism, preeclampsia and other problems individually.

Although we did observe positive effects on some aging traits, such as memory impairments and reduced red blood cell counts, our studies showed that similar drug effects are also seen in young mice, indicating that rapamycin did not influence these measures by slowing aging, but rather via other, aging - independent, mechanisms.»

Other analyses concur, finding that psychological interventions, especially CBT, have a small but noticeable effect on reducing pain in patients with fibromyalgia, similar to that observed for drug therapy.

The drug Gefitinib is used to treat breast, lung, and other cancers by inhibiting epidermal growth factor receptor (EGFR) signaling, but it has only a limited effect on prostate cancer.

To confirm that extra enzyme led to sleep deprivation's effects on memory, the scientists next tried to counteract it with rolipram, a drug that inhibits PDE4A5 and other similar PDEs.

Now, new research from Boston Children's Hospital has shed light on the mystery and points to a potential new drug for protecting the brain from the neuropsychiatric effects of lupus and other central nervous system (CNS) diseases.

New research from the University at Buffalo Research Institute on Addictions that explored the potential side effects of the stimulant drug Ritalin on those without ADHD showed changes in brain chemistry associated with risk - taking behavior, sleep disruption and other undesirable effects.

New insights about the brain are changing the way the law handles cases related to adolescent decision making, the effects of drugs on the brain, memory and lie detection, and states of consciousness, among others.